§ Mr. RoyTo ask the Secretary of State for Health what discussions he has had concerning the dangers of oestrogen to women. [160256]
§ Dr. LadymanWhen the findings from the recently terminated oestrogen-only hormone replacement therapy (HRT) arm of the Women's Health Initiative (WHI) trial are published, they will be carefully considered by the Committee on Safety of Medicines (CSM) and its expert working group on HRT. When its review is complete, any necessary action, including updating the current product information will be taken and women and doctors will be clearly informed of the advice. The Medicines and Healthcare products Regulatory Agency (MHRA) has copied in the Scottish Executive in all their communications. Further briefing can be found on the MHRA website at www.mhra.gov.uk.